MILabs wins Japanese contract

By staff writers

March 3, 2014 -- Preclinical imaging developer MILabs has installed its Vector+/CT system at Kanazawa University in Japan.

The system will be used for a broad range of projects at the division of tracer kinetics in Kanazawa's Advanced Science Research Center. The division is engaged in the study and development of radioactive molecular probes for neurodegenerative disorders such as Alzheimer's disease, as well as different types of carcinomas, MILabs said.

The system will also be used to study tumor detection and treatment with radiopharmaceuticals, combined radioimmunotherapy, and cancer drug resistance in different carcinomas such as breast, bone, and colon through the use of transgenic animals and xenograft tumor models, the firm said.

Copyright © 2014

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking